Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...

Popoln opis

Bibliografske podrobnosti

izdano v:	Ann Rheum Dis
Principais autores:	Capell, H A, Porter, D R, Madhok, R, Hunter, J A
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 1993
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005066/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8100702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.6.423
Oznake:	Označite Brez oznak, prvi označite!